早发型胎儿生长受限围产期存活预测:胎盘生长因子的作用
前瞻性观察研究纳入210例早发型胎儿生长受限单胎妊娠,诊断时行超声与母血清sFlt-1、PlGF检测。28周前诊断者围产期存活预测最佳组合为估计胎儿体重与PlGF中位数倍数(AUC 0.84),重度新生儿发病率预测效能一般(AUC 0.73)。
要点
- 诊断时估计胎儿体重与母血清PlGF中位数倍数是预测28周前诊断早发型胎儿生长受限围产期存活的最佳组合。
- 28周及以上诊断的早发型胎儿生长受限病例全部围产期存活。
- 早发型胎儿生长受限重度新生儿发病率的产前预测效能一般,AUC为0.73。
核心结论
- 联合估计胎儿体重与母血清PlGF的模型可较准确预测28周前诊断的早发型胎儿生长受限围产期存活;重度新生儿发病率产前预测效能一般。
研究设计与样本
- 前瞻性观察性研究,纳入210例早发型胎儿生长受限(<32周诊断)单胎妊娠,诊断时行超声(解剖、生物测量及多普勒)及母血清sFlt-1、PlGF检测。
关键影像表现/征象
- 28周前诊断的存活者较非存活者诊断时孕周更高(26.1 vs 24.4周),估计胎儿体重更大(626 vs 384 g)。
- 28周前诊断的存活者较非存活者诊断时脑胎盘比更高(1.1 vs 0.9)。
- 28周前诊断的存活者较非存活者诊断时PlGF更高(41 vs 18 pg/mL),PlGF中位数倍数更高(0.10 vs 0.06)。
- 28周前诊断的存活者较非存活者诊断时sFlt-1/PlGF比值更低(129 vs 479),以上差异均P<0.001。
诊断标准与关键数值
- 预测28周前诊断病例围产期存活的最佳两变量组合为估计胎儿体重与PlGF中位数倍数,AUC 0.84(95%CI 0.75-0.92)。
- 预测全部活产病例重度新生儿发病率的最佳变量同样为估计胎儿体重与PlGF中位数倍数,AUC 0.73(95%CI 0.66-0.80)。
- 早发型胎儿生长受限定义为孕周<32周诊断。
临床应用与阅片要点
- 对28周前诊断的早发型胎儿生长受限,阅片报告可结合估计胎儿体重与母血清PlGF中位数倍数评估围产期存活风险。
- 28周及以上诊断的早发型胎儿生长受限病例本研究中全部围产期存活,解读预后时需结合诊断孕周。
- 重度新生儿发病率产前预测效能一般,报告时应避免过度解读单一模型结果。
局限性
- 早发型胎儿生长受限重度新生儿发病率的产前预测效能一般,无论采用何种模型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To analyze the ability to predict perinatal survival and severe neonatal morbidity of cases with early-onset fetal growth restriction (eoFGR) using maternal variables, ultrasound parameters and angiogenic markers at the time of diagnosis.
METHODS: This was a prospective observational study in a cohort of singleton pregnancies with a diagnosis of eoFGR (< 32 weeks of gestation). At diagnosis of eoFGR, complete assessment was performed, including ultrasound examination (anatomy, biometry and Doppler assessment) and maternal serum measurement of the angiogenic biomarkers, soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF). Logistic regression models for the prediction of perinatal survival (in cases diagnosed at < 28 weeks) and severe neonatal morbidity (in all liveborn cases) were calculated.
RESULTS: In total, 210 eoFGR cases were included, of which 185 (88.1%) survived perinatally. The median gestational age at diagnosis was 27 + 0 weeks. All cases diagnosed at ≥ 28 weeks survived. In cases diagnosed < 28 weeks, survivors (vs non-survivors) had a higher gestational age (26.1 vs 24.4 weeks), estimated fetal weight (EFW; 626 vs 384 g), cerebroplacental ratio (1.1 vs 0.9), PlGF (41 vs 18 pg/mL) and PlGF multiples of the median (MoM; 0.10 vs 0.06) and lower sFlt-1/PlGF ratio (129 vs 479) at the time of diagnosis (all P < 0.001). The best combination of two variables for predicting perinatal survival was provided by EFW and PlGF MoM (area under the receiver-operating-characteristics curve (AUC), 0.84 (95% CI, 0.75-0.92)). These were also the best variables for predicting severe neonatal morbidity (AUC, 0.73 (95% CI, 0.66-0.80)).
CONCLUSIONS: A model combining EFW and maternal serum PlGF predicts accurately perinatal survival in eoFGR cases diagnosed before 28 weeks of gestation. Prenatal prediction of severe neonatal morbidity in eoFGR cases is modest regardless of the model used. © 2022 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Rodríguez-Calvo J, Villalaín C, Gómez-Arriaga PI, et al. Prediction of perinatal survival in early-onset fetal growth restriction: role of placental growth factor. Ultrasound Obstet Gynecol. 2023. PMID: 36370447. doi:10.1002/uog.26116
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。